Liraglutide's immune cell and anti-inflammatory cytokine modulation in obese Type 2 Diabetes patients investigated
Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide
Abstract
A clinical trial investigated Liraglutide's effects on immune cell counts and anti-inflammatory cytokine profiles in obese Type 2 Diabetes patients.